FKBP52

FK506 binding protein 4, 59kDa

PDB rendering based on 1n1a.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
SymbolsFKBP4 ; FKBP51; FKBP52; FKBP59; HBI; Hsp56; PPIase; p52
External IDsOMIM: 600611 MGI: 95543 HomoloGene: 36085 ChEMBL: 4050 GeneCards: FKBP4 Gene
EC number5.2.1.8
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez228814228
EnsemblENSG00000004478ENSMUSG00000030357
UniProtQ02790P30416
RefSeq (mRNA)NM_002014NM_010219
RefSeq (protein)NP_002005NP_034349
Location (UCSC)Chr 12:
2.9 – 2.91 Mb
Chr 6:
128.43 – 128.44 Mb
PubMed search

FK506-binding protein 4 is a protein that in humans is encoded by the FKBP4 gene.[1][2]

The protein encoded by this gene is a member of the immunophilin protein family, which play a role in immunoregulation and basic cellular processes involving protein folding and trafficking. This encoded protein is a cis-trans prolyl isomerase that binds to the immunosuppressants FK506 and rapamycin. It has high structural and functional similarity to FK506-binding protein 1A (FKBP1A), but unlike FKBP1A, this protein does not have immunosuppressant activity when complexed with FK506. It interacts with interferon regulatory factor-4 and plays an important role in immunoregulatory gene expression in B and T lymphocytes. This encoded protein is known to associate with phytanoyl-CoA alpha-hydroxylase. It can also associate with two heat shock proteins (hsp90 and hsp70) and thus may play a role in the intracellular trafficking of hetero-oligomeric forms of the steroid hormone receptors. This protein correlates strongly with adeno-associated virus type 2 vectors (AAV) resulting in a significant increase in AAV-mediated transgene expression in human cell lines. Thus this encoded protein is thought to have important implications for the optimal use of AAV vectors in human gene therapy. This gene has been found to have multiple polyadenylation sites.[2]

This protein contains TPR repeats and has a PPlase domain.

Recent research suggests that FKBP52 may play a role in preventing the Tau protein from turning pathogenic. This may prove significant for the development of new Alzheimer’s drugs and for detecting the disease before the onset of clinical symptoms.

Interactions

FKBP52 has been shown to interact with GLMN.[3][4]

See also

References

  1. Peattie DA, Harding MW, Fleming MA, DeCenzo MT, Lippke JA, Livingston DJ, Benasutti M (Dec 1992). "Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes". Proc Natl Acad Sci U S A 89 (22): 10974–8. doi:10.1073/pnas.89.22.10974. PMC 50465. PMID 1279700.
  2. 2.0 2.1 "Entrez Gene: FKBP4 FK506 binding protein 4, 59kDa".
  3. Chambraud, B; Radanyi C; Camonis J H; Shazand K; Rajkowski K; Baulieu E E (Dec 1996). "FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12. Prevention by the immunosuppressant drugs FK506 and rapamycin". J. Biol. Chem. (UNITED STATES) 271 (51): 32923–9. doi:10.1074/jbc.271.51.32923. ISSN 0021-9258. PMID 8955134.
  4. Neye, H (Mar 2001). "Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts the interaction with FKBP12 and FKBP52". Regul. Pept. (Netherlands) 97 (2–3): 147–52. doi:10.1016/S0167-0115(00)00206-8. ISSN 0167-0115. PMID 11164950.

Further reading


External links